SLC25A21-AS1

ncRNA information

ncRNA name

SLC25A21-AS1

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Diagnosis/Prognosis

Upstream regulatory factors

Not available

Downstream target

miR-324-3p/IL-6

Cancer information

Cancer name

Nasopharyngeal Carcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Long Non-Coding RNA SLC25A21-AS1 Promotes Multidrug Resistance in Nasopharyngeal Carcinoma by Regulating miR-324-3p/IL-6

Tissue resource

pairs of nasopharyngeal carcinoma samples and adjacent normal tissues

human nasopharyngeal epithelial cell lines NP69

human nasopharyngeal carcinoma cell lines SUNE-1

human nasopharyngeal carcinoma cell lines CNE-1

human nasopharyngeal carcinoma cell lines CNE-2

human nasopharyngeal carcinoma cell lines HNE-1

human nasopharyngeal carcinoma cell lines C666-1

human nasopharyngeal carcinoma cell lines HONE-1

Experiment

None


Institute

Liangxiang Hospital of Capital Medical University

Chinese Academy of Sciences Cell Bank

Country

China

China

Continent

Asia

Asia